ORI Capital, the venture firm behind CG’s big IPO, raises new biotech fund

cafead

Administrator
Staff member
  • cafead   Feb 22, 2024 at 11:33: PM
via The $260 million fund will be used to back startups working on new drugmaking approaches like protein degraders and RNA therapies.

article source
 

<